BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1363101)

  • 1. Tumor cell purging and positive selection of hematopoietic stem cells.
    Gee AP
    J Clin Apher; 1992; 7(3):135-7. PubMed ID: 1363101
    [No Abstract]   [Full Text] [Related]  

  • 2. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
    Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
    Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroblastoma purging by immunorosette depletion.
    Slaper-Cortenbach IC; de Vries-van Rossen A; Huijbens RJ; van Leeuwen EF; Figdor CG
    Prog Clin Biol Res; 1992; 377():147-62. PubMed ID: 1438411
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of hematopoietic stem cells: purging or selection?
    Slaper-Cortenbach IC
    Vox Sang; 1994; 67 Suppl 3():185-6. PubMed ID: 7526552
    [No Abstract]   [Full Text] [Related]  

  • 7. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
    Sieber F; Gaffney DK; Yamazaki T; Qiu K
    Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
    Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP; Rogers PC; Chan KW; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of marrow purging].
    Rizzoli V; Carlo-Stella C; Mangoni L
    Haematologica; 1991 Jun; 76 Suppl 3():311-20. PubMed ID: 1684346
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Srour EF; Tricot G; Hoffman R
    Prog Clin Biol Res; 1992; 377():231-7. PubMed ID: 1279706
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow purging with antisense oligodeoxynucleotides.
    Gewirtz AM
    Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumour cell purging for autologous bone marrow transplantation.
    Trickett AE
    Med Lab Sci; 1990 Apr; 47(2):120-31. PubMed ID: 2199741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
    Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
    Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the role of hematopoietic support for high-dose cytotoxic therapy.
    Gulati SC; Acaba L
    Cancer Invest; 1993; 11(3):319-26. PubMed ID: 8097959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic methods of purging in autologous stem cell transplantation.
    Berkahn L
    J Hematother Stem Cell Res; 2000 Apr; 9(2):147-59. PubMed ID: 10813528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.